Gave Syndrome – A Rare and Mysterious Cause of Gastrointestinal Hemorrhage in the Elderly

1. Rider, JA; Klotz, AP; Kirsner, JB (1953). “Gastritis with veno-capillary ectasia as a source of massive gastric hemorrhage”. Gastroenterology. 24 (1): 118-23.10.1016/S0016-5085(53)80070-3Open DOISearch in Google Scholar

2. Rider, JA; Klotz, AP; Kirsner, JB (1953). “Gastritis with veno-capillary ectasia as a source of massive gastric hemorrhage”. Gastroenterology. 24 (1): 118-23.1305217010.1016/S0016-5085(53)80070-3Search in Google Scholar

3. Jabbari M, Cherry R, Lough JO, Daly DS, Kinnear DG, Goresky CA. Gastric antrovascular ectasia: the watermelon stomach. Gastroenterology 1984;87:1165.10.1016/S0016-5085(84)80080-3Search in Google Scholar

4. Ward EM, Raimondo M, Rosser BG, et al. Prevalence and natural history of gastric antral vascular ectasia (GAVE) in patients undergoing orthoptic liver transplantation. Journal of Clinical Gastroenterology. 2004;38:898-90010.1097/00004836-200411000-00013Open DOISearch in Google Scholar

5. C. J.Gostout, T. R.Viggiano, D. A. Ahlquist, K. K.Wang, M. V. Larson, and R. Balm, “The clinical and endoscopic spectrum of the watermelon stomach,” Journal of Clinical Gastroenterology, vol. 15, no. 3, pp. 256–263, 199210.1097/00004836-199210000-00019Open DOISearch in Google Scholar

6. E. Quintero, J.M. Pique, J.A. Bombi et al., “Gastricmucosal vascular ectasias causing bleeding in cirrhosis: a distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I,” Gastroenterology, vol. 93, no. 5, pp. 1054–1061, 1987.10.1016/0016-5085(87)90569-5Open DOISearch in Google Scholar

7. J. R. Lowes and J. Rode, “Neuroendocrine cell proliferations in gastric antral vascular ectasia,” Gastroenterology, vol. 97, no. 1, pp. 207–212, 1989.10.1016/0016-5085(89)91437-6Search in Google Scholar

8. Gostout CJ, Viggiano TR, Ahlquist DA, Wang KK, Larson MV, Balm R. The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterology 1992;15:256-263.10.1097/00004836-199210000-00019Search in Google Scholar

9. Payen JL, Cales P, Voigt JJ, Payen JL, Calès P, Voigt JJ, Barbe S, Pilette C, Dubuisson L, Desmorat H, Vinel JP, Kervran A, Chayvialle JA. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology 1995;108:138–144.10.1016/0016-5085(95)90018-7Search in Google Scholar

10. Yusoff I, Brennan F, Ormonde D, Laurence B. Argon plasma coagulation for the treatment of watermelon stomach. Endoscopy. 2002;34:407-4101197227410.1055/s-2002-2528711972274Search in Google Scholar

11. Roman S, Saurin JC, Dumortier J, et al. Tolerance and efficacy of argon plasma coagulation for controlling bleeding in patients with typical and atypical manifestations of watermelon stomach. Endoscopy. 2003;35:1024-102810.1055/s-2003-44594Open DOISearch in Google Scholar

12. Cho S, Zanati S, Yong E, et al. Endoscopic cryotherapy for the management of gastric antral vascular ectasia. Gastrointestinal Endoscopy. 2008;68:895-90210.1016/j.gie.2008.03.1109Open DOISearch in Google Scholar

13. Wahab PJ, Mulder CJ, den Hartog G, Thies JE. Argon plasma coagulation in flexible gastrointestinal endoscopy: Pilot experiences. Endoscopy 1997;29:176-18110.1055/s-2007-1004159Open DOISearch in Google Scholar

14. Jackson CS, Gerson LB. Management of gastrointestinal angiodysplastic lesions (GIADs): A systematic review and meta-analysis. American Journal of Gastroenterology. 2014;109:474-48310.1038/ajg.2014.19Search in Google Scholar

15. Nardone G, Rocco A, Balzano T. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Alimentary Pharmacology & Therapeutics. 1999;13:1429-136310.1046/j.1365-2036.1999.00647.xSearch in Google Scholar

16. Li SC, Martijn C, Cui T, et al. The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells. PloS One. 2012;7:e4841110.1371/journal.pone.0048411Search in Google Scholar

17. Zalatnai A, Timar F. Vitro antiangiogenic effect of sandostatin (octreotide) on the proliferation of the placental vessels. Anticancer Research. 2002;22:4225-4227Search in Google Scholar

18. D. A. Papachristos, M. Nikpour, C. Hair, and W. M. Stevens, “Intravenous cyclophosphamide as a therapeutic option for severe refractory gastric antral vascular ectasia in systemic sclerosis,” Internal Medicine Journal, vol. 45, no. 10, pp. 1077–1081, 2015.10.1111/imj.12883Search in Google Scholar

19. Bhowmick BK. Watermelon stomach treated with oral corticosteroid. Journal of the Royal Society of Medicine. 1993;86:52Search in Google Scholar

20. McCormick PA, Ooi H, Crosbie O. Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut. 1998;42:750-75210.1136/gut.42.5.750Open DOISearch in Google Scholar

21. Dunne KA, Hill J, Dillon JF. Treatment of chronic transfusion-dependent gastric antral vascular ectasia (watermelon stomach) with thalidomide. European Journal of Gastroenterology & Hepatology. 2006;18:455-45610.1097/00042737-200604000-00024Search in Google Scholar

22. Cabral JE, Pontes JM, Toste M, et al. Watermelon stomach: Treatment with a serotonin antagonist. American Journal of Gastroenterology. 1991;86:927-928Search in Google Scholar

23. Novitsky YW, Kercher KW, Czerniach DR, Litwin DE. Watermelon stomach: Pathophysiology, diagnosis, and management. Journal of Gastrointestinal Surgery. 2003;7:652-66110.1016/S1091-255X(02)00435-3Open DOISearch in Google Scholar